Advertisement
Advertisement
VIVS
VivoSim Labs, Inc. Common Stock
0.23
USDSponsored
0.00
-1.62%
Sep 24, 15:55 UTC -4
Closed
Pre-Market
0.23
0.00
+1.60%
VIVS Earnings Reports
Positive Surprise Ratio
VIVS beat 19 of 22 last estimates.
86%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$51.00K
/-$0.19
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+70.00%
/-88.69%
VivoSim Labs, Inc. Common Stock earnings per share and revenue
On Aug 10, 2026, VIVS reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -0.19 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 47.94 thousand, with a --% difference. The market reacted with a -22.16% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.19 USD, with revenue projected to reach 51.00 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AYTU BioPharma, Inc. Common Stock
Report Date
Sep 22, 2026 For Q4 26
Estimate
-$0.33
Actual
-$0.05
Surprise
+84.92%
Neuphoria Therapeutics Inc. Common Stock
Report Date
Sep 18, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.95
Surprise
-66.32%
NewcelX Ltd. Ordinary Shares
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$0.54
Actual
-$0.96
Surprise
-77.58%
Abivax SA - ADR
Report Date
Sep 21, 2026 For Q2 26
Estimate
-$1.82
Actual
-$2.09
Surprise
-14.47%
AnaptysBio, Inc. Common Stock
Report Date
Sep 21, 2026 For Q2 26
Estimate
$0.00
Actual
$5.11
Surprise
>+10,000.00%
BlossomHill Therapeutics, Inc. Common Stock
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$1.03
Actual
-$8.75
Surprise
-746.56%
Vogenx Inc Common Stock
Report Date
Sep 17, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+1.96%
Benitec Biopharma Inc. Common Stock
Report Date
Sep 14, 2026 For Q4 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+5.59%
FAQ
What were VivoSim Labs, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, VivoSim Labs, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to VivoSim Labs, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -22.16%, changed from $0.47 before the earnings release to $0.36 the day after.
When is VivoSim Labs, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for VivoSim Labs, Inc. Common Stock's next earnings report?
Based on 3
analysts, VivoSim Labs, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of $51.00K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.